dinoprostone

UK Faces Critical Dinoprostone Shortage Amid Broader Pharmaceutical Supply Chain Instability

The UK faces a critical shortage of dinoprostone 3mg vaginal tablets and gels, impacting obstetric care as of April 8, 2026. This alert, alongside recent recalls of unlicensed Quetiapine and supply issues for essential IV fluids and TB antimicrobials, underscores escalating pharmaceutical supply chain fragility. Procurement and regulatory teams must proactively diversify sourcing, enhance inventory management, and monitor regulatory alerts to mitigate operational risks and ensure patient access.